16 Ku G,Faust T,Lauffer L,et al.Interleukin-β converting enzyme inhibition blocks progression of type Ⅱcollagen-induced arthritis in mice.Cytokine,1996,8:377∶386
17 Fink G,Yang J,Carter G,et al.Acute pancreatitis-induced enzyme release and necrosis are attenuated by IL-l antagonism through an indirect mechanism.J surg Res,1997,67∶94～97
18 Norman JG,Messina J,Franz M.et al.Interleukin-lreceptor antagonist decreases severity of experimental acute pancreatitis.Surgery,1995,117∶648～655
19 Lukacs NW,Kunkel SL,Burdick MO,et al.Interleukin-l receptor antagonist blocks chemokine production in the mixed lymphocyte reaction.Blood,1993,82∶3668～3674
20 Laethem JL,Eskinazi R,Louis H,et al.Muitisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice,Gut,1998,43∶408～413
21 Rongione AJ,Kusske AM,Kwan K,et al.Interleukin 10 reduces the severity of acute pancreatitis in rats.Gastroenterology,1997,112∶960～967
22 Hughes CB,Gaber LW,Mohey el-Din AB,et al.Inhibition of TNFα improves survival in an experimental model of acute pancreatitis.Am surg,1996,62∶8～13
23 Grewal HP,Mohey el-Din AB,Gaber L,et al.Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNFα polyclonal antibody.Am J Surg,1994,167∶214～219
24 Formela LJ,Wood LM,Whittaker M,et al.Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist.Br J surg,1994,81∶1783～1785
25 Kingsnorth AN,Galloway SW,Formela LJ.Randomized,double-blind phase Ⅱ trial of Lexipafant,a platelet-activating factor antagonist,in human acute pancreatitis.Br J Surg,1995,82∶1414～1420
